Australian public assessment for Eplerenone

Inspra (eplerenone) is a mineralocorticoid receptor antagonist with weak binding to androgen, glucocorticoid and progesterone receptors. It prevents the binding of aldosterone. Inspra has been considered previously by the Advisory Committee on Prescription Medicines (ACPM) on one occasion (238th (2005/1) meeting in 2005) prior to its initial ... ................
................